Keros Therapeutics Stock Price History
| KROS Stock | USD 11.44 0.02 0.18% |
Below is the normalized historical share price chart for Keros Therapeutics extending back to April 08, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Keros Therapeutics stands at 11.44, as last reported on the 20th of March, with the highest price reaching 11.55 and the lowest price hitting 11.26 during the day.
If you're considering investing in Keros Stock, it is important to understand the factors that can impact its price. Keros Therapeutics has Sharpe Ratio of -0.16, which conveys that the firm had a -0.16 % return per unit of risk over the last 3 months. Keros Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Keros Therapeutics' Risk Adjusted Performance of (0.15), standard deviation of 9.65, and Mean Deviation of 3.98 to check out the risk estimate we provide.
At this time, Keros Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 646.7 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 23.4 M in 2025. . Price Earnings To Growth Ratio is likely to gain to 0.86 in 2025, whereas Price To Sales Ratio is likely to drop 158.59 in 2025. Keros Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of April 2020 | 200 Day MA 40.2041 | 50 Day MA 11.5249 | Beta 1.396 |
Keros |
Sharpe Ratio = -0.1607
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KROS |
Estimated Market Risk
| 3.68 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.59 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Keros Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Keros Therapeutics by adding Keros Therapeutics to a well-diversified portfolio.
Price Book 0.8105 | Enterprise Value Ebitda (13.05) | Price Sales 130.484 | Shares Float 35.4 M | Wall Street Target Price 33.6364 |
Keros Therapeutics Stock Price History Chart
There are several ways to analyze Keros Stock price data. The simplest method is using a basic Keros candlestick price chart, which shows Keros Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 23, 2024 | 17.12 |
| Lowest Price | February 13, 2025 | 10.15 |
Keros Therapeutics March 20, 2025 Stock Price Synopsis
Various analyses of Keros Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Keros Stock. It can be used to describe the percentage change in the price of Keros Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Keros Stock.| Keros Therapeutics Accumulation Distribution | 8,117 | |
| Keros Therapeutics Price Rate Of Daily Change | 1.00 | |
| Keros Therapeutics Price Daily Balance Of Power | 0.07 | |
| Keros Therapeutics Price Action Indicator | 0.04 |
Keros Therapeutics March 20, 2025 Stock Price Analysis
Keros Stock Price History Data
The price series of Keros Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 58.5 with a coefficient of variation of 53.9. The daily prices for the period are spread out with arithmetic mean of 13.65. The median price for the last 90 days is 11.51.| Open | High | Low | Close | Volume | ||
| 03/20/2025 | 11.26 | 11.55 | 11.26 | 11.44 | 323,279 | |
| 03/19/2025 | 11.31 | 11.61 | 11.19 | 11.42 | 507,801 | |
| 03/18/2025 | 11.56 | 11.57 | 11.26 | 11.35 | 678,574 | |
| 03/17/2025 | 11.68 | 11.74 | 11.26 | 11.62 | 656,473 | |
| 03/14/2025 | 11.56 | 11.77 | 11.52 | 11.58 | 374,066 | |
| 03/13/2025 | 11.76 | 11.94 | 11.32 | 11.47 | 371,376 | |
| 03/12/2025 | 11.56 | 11.89 | 11.42 | 11.76 | 553,024 | |
| 03/11/2025 | 10.86 | 11.52 | 10.62 | 11.51 | 876,463 | |
| 03/10/2025 | 11.22 | 11.36 | 10.74 | 10.92 | 982,496 | |
| 03/07/2025 | 11.92 | 12.04 | 11.31 | 11.38 | 1,084,939 | |
| 03/06/2025 | 11.53 | 12.28 | 11.37 | 11.93 | 826,079 | |
| 03/05/2025 | 11.59 | 11.80 | 11.22 | 11.67 | 835,812 | |
| 03/04/2025 | 11.01 | 11.73 | 10.80 | 11.59 | 1,225,934 | |
| 03/03/2025 | 11.34 | 11.37 | 11.03 | 11.10 | 1,059,903 | |
| 02/28/2025 | 10.95 | 11.11 | 10.63 | 11.08 | 2,027,442 | |
| 02/27/2025 | 10.98 | 11.43 | 10.94 | 11.01 | 1,084,628 | |
| 02/26/2025 | 10.94 | 11.18 | 10.79 | 10.94 | 1,491,204 | |
| 02/25/2025 | 10.81 | 11.07 | 10.67 | 10.91 | 1,026,084 | |
| 02/24/2025 | 11.03 | 11.17 | 10.63 | 10.79 | 855,273 | |
| 02/21/2025 | 11.14 | 11.20 | 10.87 | 11.02 | 896,867 | |
| 02/20/2025 | 10.59 | 11.12 | 10.59 | 11.03 | 891,644 | |
| 02/19/2025 | 10.55 | 10.79 | 10.52 | 10.61 | 777,150 | |
| 02/18/2025 | 10.33 | 10.71 | 10.33 | 10.56 | 845,827 | |
| 02/14/2025 | 10.22 | 10.70 | 10.18 | 10.32 | 966,942 | |
| 02/13/2025 | 10.24 | 10.40 | 10.15 | 10.15 | 629,312 | |
| 02/12/2025 | 10.25 | 10.29 | 10.09 | 10.20 | 1,005,255 | |
| 02/11/2025 | 10.39 | 10.55 | 10.25 | 10.28 | 994,556 | |
| 02/10/2025 | 10.92 | 10.92 | 10.36 | 10.49 | 1,220,941 | |
| 02/07/2025 | 11.44 | 11.65 | 10.85 | 10.86 | 1,187,598 | |
| 02/06/2025 | 11.20 | 12.05 | 11.01 | 11.52 | 1,879,297 | |
| 02/05/2025 | 11.02 | 11.27 | 10.95 | 11.13 | 980,625 | |
| 02/04/2025 | 11.11 | 11.36 | 10.98 | 11.00 | 927,989 | |
| 02/03/2025 | 11.11 | 11.35 | 11.04 | 11.13 | 862,028 | |
| 01/31/2025 | 11.56 | 11.71 | 11.26 | 11.40 | 1,135,115 | |
| 01/30/2025 | 11.43 | 11.99 | 11.43 | 11.71 | 1,381,635 | |
| 01/29/2025 | 11.18 | 11.44 | 11.04 | 11.37 | 1,025,847 | |
| 01/28/2025 | 11.44 | 11.47 | 11.15 | 11.31 | 832,842 | |
| 01/27/2025 | 11.80 | 11.99 | 11.41 | 11.45 | 1,053,071 | |
| 01/24/2025 | 12.04 | 12.56 | 11.82 | 11.84 | 1,496,632 | |
| 01/23/2025 | 11.37 | 12.08 | 11.22 | 12.02 | 1,732,866 | |
| 01/22/2025 | 11.31 | 11.54 | 10.95 | 11.39 | 2,573,368 | |
| 01/21/2025 | 11.46 | 11.60 | 11.06 | 11.41 | 2,890,399 | |
| 01/17/2025 | 11.00 | 11.63 | 10.74 | 10.86 | 2,986,486 | |
| 01/16/2025 | 10.61 | 10.71 | 10.10 | 10.52 | 3,201,294 | |
| 01/15/2025 | 9.97 | 10.90 | 9.78 | 10.42 | 13,601,230 | |
| 01/14/2025 | 12.99 | 13.04 | 12.22 | 12.48 | 1,132,485 | |
| 01/13/2025 | 14.00 | 14.10 | 12.35 | 12.82 | 2,314,208 | |
| 01/10/2025 | 14.40 | 14.69 | 13.96 | 14.56 | 1,609,894 | |
| 01/08/2025 | 15.63 | 15.78 | 14.82 | 14.89 | 721,245 | |
| 01/07/2025 | 15.60 | 16.49 | 15.60 | 15.84 | 868,847 | |
| 01/06/2025 | 16.47 | 16.47 | 15.59 | 15.64 | 955,769 | |
| 01/03/2025 | 15.90 | 16.52 | 15.74 | 16.10 | 752,553 | |
| 01/02/2025 | 15.95 | 16.70 | 15.82 | 15.92 | 524,296 | |
| 12/31/2024 | 15.75 | 15.93 | 15.33 | 15.83 | 854,771 | |
| 12/30/2024 | 16.27 | 16.51 | 15.51 | 15.64 | 1,323,700 | |
| 12/27/2024 | 16.64 | 17.25 | 16.29 | 16.42 | 862,070 | |
| 12/26/2024 | 16.50 | 16.89 | 16.30 | 16.81 | 998,904 | |
| 12/24/2024 | 17.12 | 17.12 | 16.63 | 16.71 | 378,972 | |
| 12/23/2024 | 16.98 | 17.50 | 16.88 | 17.12 | 974,243 | |
| 12/20/2024 | 16.77 | 17.64 | 16.62 | 17.03 | 1,469,551 | |
| 12/19/2024 | 17.08 | 17.08 | 16.31 | 16.92 | 1,701,900 |
About Keros Therapeutics Stock history
Keros Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Keros is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Keros Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Keros Therapeutics stock prices may prove useful in developing a viable investing in Keros Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 37.4 M | 23.4 M | |
| Net Loss | -94.2 M | -89.5 M |
Keros Therapeutics Quarterly Net Working Capital |
|
Keros Therapeutics Stock Technical Analysis
Keros Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Keros Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Keros Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Keros Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Keros to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (1.76) | |||
| Total Risk Alpha | (0.96) | |||
| Treynor Ratio | (17.87) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Keros Stock Analysis
When running Keros Therapeutics' price analysis, check to measure Keros Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros Therapeutics is operating at the current time. Most of Keros Therapeutics' value examination focuses on studying past and present price action to predict the probability of Keros Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros Therapeutics' price. Additionally, you may evaluate how the addition of Keros Therapeutics to your portfolios can decrease your overall portfolio volatility.